LATEST MANUSCRIPTS IN Cancer Management and Research
. Isovitexin Suppresses Cancer Stemness Property and Induces Apoptosis of Osteosarcoma Cells by Disruption of the DNMT1/miR-34a/Bcl-2 Axis [Retraction].Cancer management and research. 2023, 15: 1003-1004
. Downregulation of Circ_0071589 Suppresses Cisplatin Resistance in Colorectal Cancer by Regulating the MiR-526b-3p/KLF12 Axis [Retraction].Cancer management and research. 2023, 15: 1005-1006
. Knockdown of CircCRIM1 Inhibits HDAC4 to Impede Osteosarcoma Proliferation, Migration, and Invasion and Facilitate Autophagy by Targeting miR-432-5p [Retraction].Cancer management and research. 2023, 15: 1007-1008
. miR-4429 Regulates the Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Cervical Cancer by Targeting FOXM1 [Retraction].Cancer management and research. 2023, 15: 1009-1010
. MiR-145 Regulates the Chemoresistance of Hepatic Carcinoma Cells Against 5-Fluorouracil by Targeting Toll-Like Receptor 4 [Retraction].Cancer management and research. 2023, 15: 1013-1014
Mingshuang Wu, Chenxi Pan, Yi He, Bo Yang. A Novel Nomogram for Identifying the Patients at Risk for Rapid Progression of Advanced Hormone-Sensitive Prostate Cancer.Cancer management and research. 2023, 15: 1015-1024
Pedro Luiz Serrano Uson Junior, Mitesh J Borad. Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date.Cancer management and research. 2023, 15: 1025-1031
Shunji Takahashi, Koji Matsumoto, Kojiro Ohba, Yasuhiro Nakano, Yasushi Miyazawa, Takumi Kawaguchi. The Incidence and Management of Cancer-Related Anorexia During Treatment with Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors.Cancer management and research. 2023, 15: 1033-1046
Yekosani Mitala, Brian Ssenkumba, Rita Nabulya, Francis Nsumba Kitenda, Habert Tumwesigye, Abraham Birungi, Richard Dratu Chau, Branchard Mushabe, Nichole Baker, Raymond Atwine. Primary Breast Burkitt Lymphoma. A Case Report of a 16-Year-Old Female with a Rapidly Growing Unilateral Breast Mass.Cancer management and research. 2023, 15: 1047-1052
Jiahui Wu, Huidan Luo, Kun Wang, Bin Yi. Development and Validation of a Novel Diagnostic Nomogram Model Using Serum Oxidative Stress Markers and AURKA for Prediction of Nasopharyngeal Carcinoma.Cancer management and research. 2023, 15: 1053-1062
Veronica Agostinelli, Lucia Musacchio, Floriana Camarda, Vanda Salutari, Maria Vittoria Carbone, Viola Ghizzoni, Camilla Nero, Caterina Ricci, Maria Teresa Perri, Elena Giudice, Sara Lardino, Rossana Berardi, Giovanni Scambia, Domenica Lorusso. Therapeutic Potential of Tisotumab Vedotin in the Treatment of Recurrent or Metastatic Cervical Cancer: A Short Report on the Emerging Data.Cancer management and research. 2023, 15: 1063-1072
Haitao Li, Shengjin Fan, Dongxue Lu, Jin Zhou. A New Scoring System for Predicting Mortality in Hematological Malignancies with Sepsis: A Derivation and Validation Study.Cancer management and research. 2023, 15: 1073-1083
Eda Caliskan Yildirim, Yusuf Acikgoz, Yakup Ergun, Efnan Algin, Oznur Bal. Treatment Outcomes and Prognostic Factors in N3 Stage Gastric Cancer After Curative Resection: A Real World Data.Cancer management and research. 2023, 15: 1085-1096
ZhenDong Liu, YuYang Xu, Shan Jin, Xin Liu, BaoChun Wang. Construction of a Prognostic Model Based on Methylation-Related Genes in Patients with Colon Adenocarcinoma.Cancer management and research. 2023, 15: 1097-1110